Long GV, Robert C, Butler MO, Couture F, et al. Standard-Dose Pembrolizumab Plus Alternate-Dose Ipilimumab in Advanced Melanoma: KEYNOTE-029 Cohort 1C, a Phase 2 Randomized Study of Two Dosing Schedules. Clin Cancer Res 2021 Jul 1. pii: 1078-0432.CCR-21-0793.
PMID: 34210681